We specialize in R & D and manufacturing, and wholesale high-quality products. We have the perfect after-sales service and technical support. Look forward to your cooperation!
We are a new manufacturer, exporter & supplier of Caffeine Anhydrous. The CAS Number of Caffeine Anhydrous is 58-08-2 . The most common end use is Beverages, Neutraceuticals, Pharmaceuticals.
We keep regular stock out of China,This avoids export license restrictions and enables rapid response for customer requirements, no need 40-50 days license waiting, goods can be shipped immediately after receiving payment.
CAS:9011-18-1
Appearance:White to off-white powder
Usage：Hypolipidemic and anti-atherosclerotic drugs.
Cas number: 351994-94-0
Molecular Weight: 284.4g/mol
Molecular Formula: C12H16N2O2S2
Emeramide, also known as BDTH2, NBMI, or [N1, N3-Bis-(2-Mercaptoethyl) Isophthalamide], is a white to off-white solid organically synthesized in the lab.
It is insoluble in water but easily soluble in fat or lipids.
CAS:82159-09-9
Appearance: Deep red needle-like crystals, smelly and bitter. Melting point 210～217°C (ethanol-water).
Usage：Aldose reductase inhibitors can reversibly inhibit the aldose reductase that converts glucose into sorbitol. It is used to improve the conscious symptoms, vibration paresthesia, and abnormal heartbeat caused by diabetic nerve ending disorders.
Used to prevent and treat diabetes
Fotagliptin benzoate 1403496-40-1
Fotagliptin benzoate is a Dipeptidyl Peptidase IV (DPP-4) inhibitor (IC50=2.27 nM). Fotagliptin benzoate displays great security in rat and dog. Fotagliptin benzoate can be used for Type 2 diabetes mellitus research[1].
CAS: 6108-05-0
Appearance:White crystal powder
Usage：This product is an amide local anesthetic. Widely used in surface anesthesia, infiltration anesthesia, conduction anesthesia and epidural anesthesia
CAS:550-99-2
Appearance:white or almost white Crystalline Powder
Usage：It is a vasoconstrictor and a sympathomimetic amine derived from imidazoline.
DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9.IC50 value: 15 nM [1]Target: DPP4 inhibitorDBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated. DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetesmellitus.
All information we received Will be used in accordance with our Privacy Policy
